Wutah dodolan YoY sajrone rolas wulan kepungkur: Crinetics Corp (CRNX)

Logo grafis Crinetics Corp (CRNX)

Crinetics Pharmaceuticals (CRNX) is implementing unique oral treatments for rare endocrine pathologies, replacing injections. A diverse range of therapeutic programs minimizes patent and clinical risks. Future monopoly status will allow the company to establish premium pricing for its therapies. This daily price chart of year-over-year sales over 12 months, provided by GURU.Markets, confirms a trend where the indicator level stands at 2919.80.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Crinetics Pharma (CRNX) kanggo 11.02.2024 - 12.09.2026

Crinetics Pharmaceuticals, Inc. (CRNX) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Crinetics Pharma
Produk seri Crinetics

For Crinetics Pharmaceuticals (CRNX), this indicator serves as a measure of the commercialization efficiency of innovative treatments for endocrine pathologies. By analyzing the year-over-year (YoY) trend of core revenue over a rolling 12-month period, an investor can track the percentage change in total annual income with daily updates. Growth confirms the scaling of the business driven by physician confidence in the brand's oral medications. Local dips here allow for the differentiation of temporary market corrections from systemic management issues.

Karo sapa Crinetics Pharmaceuticals saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur newamsterdampharma.com (NAMS)|Wutah pendapatan YoY sajrone 12 wulan kepungkur soleno.life SLNO|Wutah dodolan YoY (TTM) FOLD (amicusrx.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur 89bio (ETNB)|Agios - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)